UMB Bank n.a. grew its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 1.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 74,351 shares of the financial services provider's stock after purchasing an additional 1,068 shares during the quarter. UMB Bank n.a.'s holdings in CME Group were worth $20,493,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also modified their holdings of CME. Wayfinding Financial LLC purchased a new position in CME Group during the first quarter valued at approximately $25,000. Webster Bank N. A. boosted its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after purchasing an additional 60 shares during the period. Cornerstone Planning Group LLC boosted its holdings in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 55 shares during the period. Golden State Wealth Management LLC boosted its holdings in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares during the period. Finally, Ransom Advisory Ltd bought a new stake in CME Group during the 1st quarter valued at approximately $31,000. Hedge funds and other institutional investors own 87.75% of the company's stock.
Analysts Set New Price Targets
Several brokerages recently weighed in on CME. Oppenheimer increased their target price on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. UBS Group reduced their price objective on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research report on Monday, September 8th. Barclays set a $298.00 price target on shares of CME Group and gave the company an "equal weight" rating in a report on Thursday, July 24th. Citigroup increased their price target on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Finally, Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $260.60.
Read Our Latest Stock Report on CME
CME Group Stock Up 0.2%
Shares of NASDAQ CME traded up $0.52 during trading on Tuesday, hitting $261.60. The stock had a trading volume of 497,067 shares, compared to its average volume of 2,275,499. The firm has a fifty day moving average of $271.66 and a two-hundred day moving average of $270.86. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The company has a market capitalization of $94.28 billion, a PE ratio of 25.30, a PEG ratio of 4.73 and a beta of 0.43. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the company earned $2.56 earnings per share. The business's revenue for the quarter was up 10.4% on a year-over-year basis. As a group, equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 48.40%.
Insider Buying and Selling
In other CME Group news, Director William R. Shepard acquired 256 shares of the business's stock in a transaction dated Wednesday, June 25th. The stock was purchased at an average price of $270.53 per share, with a total value of $69,255.68. Following the transaction, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Sunil Cutinho sold 11,896 shares of the business's stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,043 shares of company stock valued at $3,527,956 over the last ninety days. Insiders own 0.30% of the company's stock.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.